Global Azithromycin API Supply, Demand and Key Producers, 2024-2030

Publication ID:

GIR032413807

Publication Date:

March 27, 2024

Pages:

128

Publisher:

GIR

Countries:

Global [1]

USD 4,480.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global Azithromycin API market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
This report studies the global Azithromycin API production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Azithromycin API, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Azithromycin API that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Azithromycin API total production and demand, 2019-2030, (Tons)
Global Azithromycin API total production value, 2019-2030, (USD Million)
Global Azithromycin API production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (Tons)
Global Azithromycin API consumption by region & country, CAGR, 2019-2030 & (Tons)
U.S. VS China: Azithromycin API domestic production, consumption, key domestic manufacturers and share
Global Azithromycin API production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (Tons)
Global Azithromycin API production by Type, production, value, CAGR, 2019-2030, (USD Million) & (Tons)
Global Azithromycin API production by Application production, value, CAGR, 2019-2030, (USD Million) & (Tons).
This reports profiles key players in the global Azithromycin API market based on the following parameters 鈥� company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shanghai Shyndec Pharmaceutical, Guobang Pharma, CSPC Pharmaceutical Group, Nexchem Pharmaceutical, HEC Pharma, Ningxia Qiyuan Pharmaceutical, Teva, Atom Pharma and Century Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Azithromycin API market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Azithromycin API 麻豆原创, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Azithromycin API 麻豆原创, Segmentation by Type
Azithromycin Dihydrate
Azithromycin Monohydrate
Global Azithromycin API 麻豆原创, Segmentation by Application
Tablet
Injection
Other
Companies Profiled:
Shanghai Shyndec Pharmaceutical
Guobang Pharma
CSPC Pharmaceutical Group
Nexchem Pharmaceutical
HEC Pharma
Ningxia Qiyuan Pharmaceutical
Teva
Atom Pharma
Century Pharmaceuticals
Anuh Pharma Ltd
Jubilant Pharmova Limite
Vadsp Pharmaceuticals
Mehta Pharmaceutical
Key Questions Answered
1. How big is the global Azithromycin API market?
2. What is the demand of the global Azithromycin API market?
3. What is the year over year growth of the global Azithromycin API market?
4. What is the production and production value of the global Azithromycin API market?
5. Who are the key producers in the global Azithromycin API market?

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Supply Summary
1.1 Azithromycin API Introduction
1.2 World Azithromycin API Supply & Forecast
1.2.1 World Azithromycin API Production Value (2019 & 2023 & 2030)
1.2.2 World Azithromycin API Production (2019-2030)
1.2.3 World Azithromycin API Pricing Trends (2019-2030)
1.3 World Azithromycin API Production by Region (Based on Production Site)
1.3.1 World Azithromycin API Production Value by Region (2019-2030)
1.3.2 World Azithromycin API Production by Region (2019-2030)
1.3.3 World Azithromycin API Average Price by Region (2019-2030)
1.3.4 North America Azithromycin API Production (2019-2030)
1.3.5 Europe Azithromycin API Production (2019-2030)
1.3.6 China Azithromycin API Production (2019-2030)
1.3.7 Japan Azithromycin API Production (2019-2030)
1.4 麻豆原创 Drivers, Restraints and Trends
1.4.1 Azithromycin API 麻豆原创 Drivers
1.4.2 Factors Affecting Demand
1.4.3 Azithromycin API Major 麻豆原创 Trends
2 Demand Summary
2.1 World Azithromycin API Demand (2019-2030)
2.2 World Azithromycin API Consumption by Region
2.2.1 World Azithromycin API Consumption by Region (2019-2024)
2.2.2 World Azithromycin API Consumption Forecast by Region (2025-2030)
2.3 United States Azithromycin API Consumption (2019-2030)
2.4 China Azithromycin API Consumption (2019-2030)
2.5 Europe Azithromycin API Consumption (2019-2030)
2.6 Japan Azithromycin API Consumption (2019-2030)
2.7 South Korea Azithromycin API Consumption (2019-2030)
2.8 ASEAN Azithromycin API Consumption (2019-2030)
2.9 India Azithromycin API Consumption (2019-2030)
3 World Azithromycin API Manufacturers Competitive Analysis
3.1 World Azithromycin API Production Value by Manufacturer (2019-2024)
3.2 World Azithromycin API Production by Manufacturer (2019-2024)
3.3 World Azithromycin API Average Price by Manufacturer (2019-2024)
3.4 Azithromycin API Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Azithromycin API Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Azithromycin API in 2023
3.5.3 Global Concentration Ratios (CR8) for Azithromycin API in 2023
3.6 Azithromycin API 麻豆原创: Overall Company Footprint Analysis
3.6.1 Azithromycin API 麻豆原创: Region Footprint
3.6.2 Azithromycin API 麻豆原创: Company Product Type Footprint
3.6.3 Azithromycin API 麻豆原创: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of 麻豆原创 Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
4.1 United States VS China: Azithromycin API Production Value Comparison
4.1.1 United States VS China: Azithromycin API Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Azithromycin API Production Value 麻豆原创 Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Azithromycin API Production Comparison
4.2.1 United States VS China: Azithromycin API Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Azithromycin API Production 麻豆原创 Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Azithromycin API Consumption Comparison
4.3.1 United States VS China: Azithromycin API Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Azithromycin API Consumption 麻豆原创 Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Azithromycin API Manufacturers and 麻豆原创 Share, 2019-2024
4.4.1 United States Based Azithromycin API Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Azithromycin API Production Value (2019-2024)
4.4.3 United States Based Manufacturers Azithromycin API Production (2019-2024)
4.5 China Based Azithromycin API Manufacturers and 麻豆原创 Share
4.5.1 China Based Azithromycin API Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Azithromycin API Production Value (2019-2024)
4.5.3 China Based Manufacturers Azithromycin API Production (2019-2024)
4.6 Rest of World Based Azithromycin API Manufacturers and 麻豆原创 Share, 2019-2024
4.6.1 Rest of World Based Azithromycin API Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Azithromycin API Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Azithromycin API Production (2019-2024)
5 麻豆原创 Analysis by Type
5.1 World Azithromycin API 麻豆原创 Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Azithromycin Dihydrate
5.2.2 Azithromycin Monohydrate
5.3 麻豆原创 Segment by Type
5.3.1 World Azithromycin API Production by Type (2019-2030)
5.3.2 World Azithromycin API Production Value by Type (2019-2030)
5.3.3 World Azithromycin API Average Price by Type (2019-2030)
6 麻豆原创 Analysis by Application
6.1 World Azithromycin API 麻豆原创 Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Tablet
6.2.2 Injection
6.2.3 Other
6.3 麻豆原创 Segment by Application
6.3.1 World Azithromycin API Production by Application (2019-2030)
6.3.2 World Azithromycin API Production Value by Application (2019-2030)
6.3.3 World Azithromycin API Average Price by Application (2019-2030)
7 Company Profiles
7.1 Shanghai Shyndec Pharmaceutical
7.1.1 Shanghai Shyndec Pharmaceutical Details
7.1.2 Shanghai Shyndec Pharmaceutical Major Business
7.1.3 Shanghai Shyndec Pharmaceutical Azithromycin API Product and Services
7.1.4 Shanghai Shyndec Pharmaceutical Azithromycin API Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.1.5 Shanghai Shyndec Pharmaceutical Recent Developments/Updates
7.1.6 Shanghai Shyndec Pharmaceutical Competitive Strengths & Weaknesses
7.2 Guobang Pharma
7.2.1 Guobang Pharma Details
7.2.2 Guobang Pharma Major Business
7.2.3 Guobang Pharma Azithromycin API Product and Services
7.2.4 Guobang Pharma Azithromycin API Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.2.5 Guobang Pharma Recent Developments/Updates
7.2.6 Guobang Pharma Competitive Strengths & Weaknesses
7.3 CSPC Pharmaceutical Group
7.3.1 CSPC Pharmaceutical Group Details
7.3.2 CSPC Pharmaceutical Group Major Business
7.3.3 CSPC Pharmaceutical Group Azithromycin API Product and Services
7.3.4 CSPC Pharmaceutical Group Azithromycin API Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.3.5 CSPC Pharmaceutical Group Recent Developments/Updates
7.3.6 CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
7.4 Nexchem Pharmaceutical
7.4.1 Nexchem Pharmaceutical Details
7.4.2 Nexchem Pharmaceutical Major Business
7.4.3 Nexchem Pharmaceutical Azithromycin API Product and Services
7.4.4 Nexchem Pharmaceutical Azithromycin API Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.4.5 Nexchem Pharmaceutical Recent Developments/Updates
7.4.6 Nexchem Pharmaceutical Competitive Strengths & Weaknesses
7.5 HEC Pharma
7.5.1 HEC Pharma Details
7.5.2 HEC Pharma Major Business
7.5.3 HEC Pharma Azithromycin API Product and Services
7.5.4 HEC Pharma Azithromycin API Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.5.5 HEC Pharma Recent Developments/Updates
7.5.6 HEC Pharma Competitive Strengths & Weaknesses
7.6 Ningxia Qiyuan Pharmaceutical
7.6.1 Ningxia Qiyuan Pharmaceutical Details
7.6.2 Ningxia Qiyuan Pharmaceutical Major Business
7.6.3 Ningxia Qiyuan Pharmaceutical Azithromycin API Product and Services
7.6.4 Ningxia Qiyuan Pharmaceutical Azithromycin API Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.6.5 Ningxia Qiyuan Pharmaceutical Recent Developments/Updates
7.6.6 Ningxia Qiyuan Pharmaceutical Competitive Strengths & Weaknesses
7.7 Teva
7.7.1 Teva Details
7.7.2 Teva Major Business
7.7.3 Teva Azithromycin API Product and Services
7.7.4 Teva Azithromycin API Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.7.5 Teva Recent Developments/Updates
7.7.6 Teva Competitive Strengths & Weaknesses
7.8 Atom Pharma
7.8.1 Atom Pharma Details
7.8.2 Atom Pharma Major Business
7.8.3 Atom Pharma Azithromycin API Product and Services
7.8.4 Atom Pharma Azithromycin API Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.8.5 Atom Pharma Recent Developments/Updates
7.8.6 Atom Pharma Competitive Strengths & Weaknesses
7.9 Century Pharmaceuticals
7.9.1 Century Pharmaceuticals Details
7.9.2 Century Pharmaceuticals Major Business
7.9.3 Century Pharmaceuticals Azithromycin API Product and Services
7.9.4 Century Pharmaceuticals Azithromycin API Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.9.5 Century Pharmaceuticals Recent Developments/Updates
7.9.6 Century Pharmaceuticals Competitive Strengths & Weaknesses
7.10 Anuh Pharma Ltd
7.10.1 Anuh Pharma Ltd Details
7.10.2 Anuh Pharma Ltd Major Business
7.10.3 Anuh Pharma Ltd Azithromycin API Product and Services
7.10.4 Anuh Pharma Ltd Azithromycin API Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.10.5 Anuh Pharma Ltd Recent Developments/Updates
7.10.6 Anuh Pharma Ltd Competitive Strengths & Weaknesses
7.11 Jubilant Pharmova Limite
7.11.1 Jubilant Pharmova Limite Details
7.11.2 Jubilant Pharmova Limite Major Business
7.11.3 Jubilant Pharmova Limite Azithromycin API Product and Services
7.11.4 Jubilant Pharmova Limite Azithromycin API Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.11.5 Jubilant Pharmova Limite Recent Developments/Updates
7.11.6 Jubilant Pharmova Limite Competitive Strengths & Weaknesses
7.12 Vadsp Pharmaceuticals
7.12.1 Vadsp Pharmaceuticals Details
7.12.2 Vadsp Pharmaceuticals Major Business
7.12.3 Vadsp Pharmaceuticals Azithromycin API Product and Services
7.12.4 Vadsp Pharmaceuticals Azithromycin API Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.12.5 Vadsp Pharmaceuticals Recent Developments/Updates
7.12.6 Vadsp Pharmaceuticals Competitive Strengths & Weaknesses
7.13 Mehta Pharmaceutical
7.13.1 Mehta Pharmaceutical Details
7.13.2 Mehta Pharmaceutical Major Business
7.13.3 Mehta Pharmaceutical Azithromycin API Product and Services
7.13.4 Mehta Pharmaceutical Azithromycin API Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.13.5 Mehta Pharmaceutical Recent Developments/Updates
7.13.6 Mehta Pharmaceutical Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Azithromycin API Industry Chain
8.2 Azithromycin API Upstream Analysis
8.2.1 Azithromycin API Core Raw Materials
8.2.2 Main Manufacturers of Azithromycin API Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Azithromycin API Production Mode
8.6 Azithromycin API Procurement Model
8.7 Azithromycin API Industry Sales Model and Sales Channels
8.7.1 Azithromycin API Sales Model
8.7.2 Azithromycin API Typical Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

Companies Mentioned:

Shanghai Shyndec Pharmaceutical
Guobang Pharma
CSPC Pharmaceutical Group
Nexchem Pharmaceutical
HEC Pharma
Ningxia Qiyuan Pharmaceutical
Teva
Atom Pharma
Century Pharmaceuticals
Anuh Pharma Ltd
Jubilant Pharmova Limite
Vadsp Pharmaceuticals
Mehta Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.